Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- DRD -6.7%, NWL -3%, NAT -2.2%, ATW -1.2%, AINV -1.2%, CNA -0.5%
M&A news:
- DHT -1% (rejects Frontline's (FRO) proposal)
Select financial related names showing weakness:
- SAN -2.3%, DB -1.6%, RBS -1.4%, CS -1.2%, BBVA -1%
Other news:
- SHIP -8.3% (entered into equity distribution agreement with Maxim to offer and sell up to $20 million of its common shares)
- PETX -6.6% (provides business update)
- TIF -4.4% (CEO steps down, co commences search successor; downgraded to Neutral from Buy at Mizuho)
- MDWD -4.1% (EMA has endorsed the extension of the Children Innovative Debridement Study population to include patients age one to 18; co will initiate the second stage of the study)
- NXTD -3.8% (files to withdraw Registration Statement on Form S-3 filed Sept 30, 2016)
- CACC -2.4% (received CID on Nov 7 from the FTC seeking information on the polices, practices and procedures in allowing car dealers to use GPS Starter Interrupters on consumer vehicles)
Analyst comments:
- BLUE -4.5% (downgraded to Neutral from Buy at ROTH Capital)
- VSTO -1.8% (downgraded to Neutral from Buy at DA Davidson)
- IP -1.2% (downgraded to Underweight from Equal Weight at Barclays )
- AZN -0.6% (downgraded to Sell from Hold at Shore Capital)
- AN -0.5% (downgraded to Hold from Buy at Evercore ISI)